Search research articles
Contact Us
Filters
Showing results (811-820 of 1,054) with videos related to
Page
of 106
Sort By:
Cancer
|
November 26, 2008
Comparison of models to predict clinical failure after radical prostatectomy
Scott E Eggener, Andrew J Vickers, Angel M Serio, et al.
The American Journal of Pathology
|
June 21, 2011
KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients
Virginia Cebrian, Marta Fierro, Esteban Orenes-Piñero, et al.
Cancer Research
|
April 18, 2001
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2
M Esteller, C Cordon-Cardo, P G Corn, et al.
The Journal of Infectious Diseases
|
April 10, 2021
Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
Suzane Ramos da Silva, Enguo Ju, Wen Meng, et al.
Nature
|
June 15, 2017
PTEN counteracts FBXL2 to promote IP3R3- and Ca<sup>2+</sup>-mediated apoptosis limiting tumour growth
Shafi Kuchay, Carlotta Giorgi, Daniele Simoneschi, et al.
Scientific Reports
|
February 22, 2020
Towards standardisation of contact and contactless electrical measurements of CVD graphene at the macro-, micro- and nano-scale
Christos Melios, Nathaniel Huang, Luca Callegaro, et al.
The Journal of Antimicrobial Chemotherapy
|
July 22, 2021
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort
Elisa de Lazzari, Ana Gonzalez-Cordon, Alexy Inciarte, et al.
Clinical Epidemiology
|
May 23, 2018
Validity of a method for the self-screening of cardiovascular risk
María Barroso, Silvia Pérez-Fernández, M Mar Vila, et al.
Science Signaling
|
January 30, 2009
Differential requirement of mTOR in postmitotic tissues and tumorigenesis
Caterina Nardella, Arkaitz Carracedo, Andrea Alimonti, et al.
The Journal of Antimicrobial Chemotherapy
|
August 2, 2020
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease
Ana Gonzalez-Cordon, Lambert Assoumou, Miguel Camafort, et al.
Page
of 106
Search research articles
Search
Showing results (811-820 of 1,054) with videos related to
Sort By:
Page
of 106
Cancer
|
November 26, 2008
Comparison of models to predict clinical failure after radical prostatectomy
Scott E Eggener, Andrew J Vickers, Angel M Serio, et al.
The American Journal of Pathology
|
June 21, 2011
KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients
Virginia Cebrian, Marta Fierro, Esteban Orenes-Piñero, et al.
Cancer Research
|
April 18, 2001
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2
M Esteller, C Cordon-Cardo, P G Corn, et al.
The Journal of Infectious Diseases
|
April 10, 2021
Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
Suzane Ramos da Silva, Enguo Ju, Wen Meng, et al.
Nature
|
June 15, 2017
PTEN counteracts FBXL2 to promote IP3R3- and Ca<sup>2+</sup>-mediated apoptosis limiting tumour growth
Shafi Kuchay, Carlotta Giorgi, Daniele Simoneschi, et al.
Scientific Reports
|
February 22, 2020
Towards standardisation of contact and contactless electrical measurements of CVD graphene at the macro-, micro- and nano-scale
Christos Melios, Nathaniel Huang, Luca Callegaro, et al.
The Journal of Antimicrobial Chemotherapy
|
July 22, 2021
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort
Elisa de Lazzari, Ana Gonzalez-Cordon, Alexy Inciarte, et al.
Clinical Epidemiology
|
May 23, 2018
Validity of a method for the self-screening of cardiovascular risk
María Barroso, Silvia Pérez-Fernández, M Mar Vila, et al.
Science Signaling
|
January 30, 2009
Differential requirement of mTOR in postmitotic tissues and tumorigenesis
Caterina Nardella, Arkaitz Carracedo, Andrea Alimonti, et al.
The Journal of Antimicrobial Chemotherapy
|
August 2, 2020
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease
Ana Gonzalez-Cordon, Lambert Assoumou, Miguel Camafort, et al.
Page
of 106